Molecular background of the Finnish disease heritage.

Finland has a population with a history revealing features of founder effect, genetic drift and isolation. Relatively small founder populations have slowly inhabited a large country and internal isolates have developed within Finland. This is reflected even today in the regional enrichment of some diseases belonging to the Finnish disease heritage. This concept was launched before the DNA era by skillful clinicians and today it comprises some 30 diseases with a wide variety of clinical phenotypes. Special strategies have been adapted in the initial locus assignment and in the restriction of the critical chromosomal DNA region having so far resulted in the successful isolation of 11 disease genes. Detailed analyses of these disease genes and their function have provided new insights into the structure and function of defective proteins as well as into the biology of affected tissues.

[1]  J. Rouvinen,et al.  Several cooperating binding sites mediate the interaction of a lysosomal enzyme with phosphotransferase , 1997, The EMBO journal.

[2]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[3]  L. Peltonen,et al.  Primary Folding of Aspartylglucosaminidase , 1996, The Journal of Biological Chemistry.

[4]  L. Peltonen,et al.  The age of human mutation: genealogical and linkage disequilibrium analysis of the CLN5 mutation in the Finnish population. , 1996, American journal of human genetics.

[5]  J. Witte,et al.  Genetic dissection of complex traits. , 1994, Nature genetics.

[6]  L. Peltonen,et al.  Three-dimensional structure of human lysosomal aspartylglucosaminidase , 1995, Nature Structural Biology.

[7]  L. Peltonen,et al.  Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis , 1995, Nature.

[8]  L. Peltonen,et al.  Random search for shared chromosomal regions in four affected individuals: the assignment of a new hereditary ataxia locus. , 1995, American journal of human genetics.

[9]  L. Jorde.  Linkage disequilibrium as a gene-mapping tool. , 1995, American journal of human genetics.

[10]  Eric S. Lander,et al.  The diastrophic dysplasia gene encodes a novel sulfate transporter: Positional cloning by fine-structure linkage disequilibrium mapping , 1994, Cell.

[11]  L. Peltonen,et al.  Dissection of the molecular consequences of a double mutation causing a human lysosomal disease. , 1994, DNA and cell biology.

[12]  V. Kaartinen,et al.  Aspartylglycosaminuria: protein chemistry and molecular biology of the most common lysosomal storage disorder of glycoprotein degradation , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  A. Chapelle,et al.  Disease gene mapping in isolated human populations: the example of Finland. , 1993, Journal of medical genetics.

[14]  Eric Lander,et al.  Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland , 1992, Nature Genetics.

[15]  L. Peltonen,et al.  Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: application to aspartylglucosaminuria in Finland. , 1992, Genomics.

[16]  L. Peltonen,et al.  Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease. , 1991, The EMBO journal.

[17]  H. Rothschild.  Biocultural aspects of diseases. , 1981 .

[18]  J. Perheentupa,et al.  Hereditary diseases in Finland; rare flora in rare soul. , 1973, Annals of clinical research.

[19]  H. Nevanlinna.  The Finnish population structure. A genetic and genealogical study. , 2009, Hereditas.

[20]  M. Delbrück,et al.  Mutations of Bacteria from Virus Sensitivity to Virus Resistance. , 1943, Genetics.